Last reviewed: June 7, 2026 Last updated: June 7, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
In this episode, Jake welcomes Gary Brecka to dive into the fascinating world of health optimisation
Our commitment to bioavailability means we look at the molecular structure of every nutrient
For researchers looking to study this powerful combination, our Wolverine Peptide Stack conveniently combines BPC 157 and TB 500
The two are complementary and non-redundant: GHK-Cu for dermis and adnexae, BPC-157+TB-500 for deep structures (tendons, ligaments, muscles, gut)
However, genetic predisposition is not destinylifestyle, nutrition, and biomarker status also matter significantly